DrugPatentWatch Database Preview
Biologic Patents Expiring in 2028
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Biologic Patents With Estimated Expirations in 2028
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | IBC Pharmaceuticals, Inc. (Morris Plains, NJ) | 2028-04-10 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | ABRAXIS BIOSCIENCE, LLC (Los Angeles, CA) | 2028-12-05 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2028-08-21 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Gilead Sciences, Inc. (Foster City, CA) | 2028-07-28 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
